This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Kyowa Hakko Kirin Co., Limited. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Dayao Zhao: Innovator in Restless Legs Syndrome Treatment
Introduction
Dayao Zhao is a notable inventor based in Mystic, CT (US). He has made significant contributions to the field of medicine, particularly in the treatment of restless legs syndrome and related disorders. His innovative approach has led to the development of a unique patent that addresses this common condition.
Latest Patents
Dayao Zhao holds a patent for "Adenosine A2A receptor antagonists for treating restless legs syndrome or nocturnal myoclonus." This invention provides methods for treating restless legs syndrome by administering an effective amount of at least one adenosine A2A receptor antagonist to patients in need. More specifically, the adenosine A2A receptor antagonist is preferably a xanthine derivative or a pharmaceutically acceptable salt thereof. This patent highlights Zhao's commitment to improving patient care through innovative solutions.
Career Highlights
Throughout his career, Dayao Zhao has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Kyowa Hakko Kirin Co., Limited and Kyowa Hakko Kogyo Co., Ltd. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Dayao Zhao has collaborated with esteemed colleagues in his field, including Hiroshi Kase and Naoki Seno. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in medical research.
Conclusion
In summary, Dayao Zhao is a distinguished inventor whose work in developing treatments for restless legs syndrome has made a significant impact in the medical field. His innovative patent and collaborations with industry leaders underscore his dedication to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
